COVID-19 Request Received
Thank you for getting in touch with us regarding your interest in COVID-19 biosamples. Our team will be in touch as soon as possible.
We remain committed to doing everything we can to support ongoing research in this area, and we appreciate your feedback and participation as we work to deliver the critical research materials you need. Thank you for allowing us to be part of the work you do!
Your source for all things biotech
Stay informed with our expert insights, industry news, and groundbreaking discoveries.
Targeting VEGF could do more harm than good in the eye
Preclinical studies have raised a potential red flag on anti-VEGF therapies, suggesting that increasingly aggressive use in eye disease could trip...
New References Published
Innovative Research has had several new references in publications over the past week. Below are just a few of the...
Fate's tissue regeneration proteins validated in vivo
San Diego-based Fate Therapeutics, which focuses on the discovery and development of adult stem cell modulators, has announced that its...
Kancera credits new drug with slowing pancreatic cancer tumor growth
From the FierceBiotech Article: Swedish drug developer Kancera says it has slowed the growth of pancreatic cancer tumors in preclinical...
Amgen enzyme combats obesity, diabetes in monkeys
Amgen (AMGN) has an interesting new weapon in the battle againstobesity. The company's scientists successfully used an antibody they discovered...
